These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38946173)

  • 21. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
    Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
    Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.
    Zheng Y; Yao Y; Ge T; Ge S; Jia R; Song X; Zhuang A
    J Exp Clin Cancer Res; 2023 Nov; 42(1):291. PubMed ID: 37924140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
    Li Z; Sun C; Qin Z
    Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.
    Wang J; Zhang W; Liu C; Wang L; Wu J; Sun C; Wu Q
    Int J Biol Sci; 2024; 20(5):1884-1904. PubMed ID: 38481820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic reprogramming of immune cells in pancreatic cancer progression.
    Xiang H; Yang R; Tu J; Xi Y; Yang S; Lv L; Zhai X; Zhu Y; Dong D; Tao X
    Biomed Pharmacother; 2023 Jan; 157():113992. PubMed ID: 36395610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell metabolism: cancer's Achilles' heel.
    Kroemer G; Pouyssegur J
    Cancer Cell; 2008 Jun; 13(6):472-82. PubMed ID: 18538731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia and cancer cell metabolism.
    Huang D; Li C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting dysregulated lipid metabolism in the tumor microenvironment.
    Kim DH; Song NY; Yim H
    Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in reprogramming of energy metabolism in tumor T cells.
    Xuekai L; Yan S; Jian C; Yifei S; Xinyue W; Wenyuan Z; Shuwen H; Xi Y
    Front Immunol; 2024; 15():1347181. PubMed ID: 38415258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic reprogramming in the tumor microenvironment of liver cancer.
    Lin J; Rao D; Zhang M; Gao Q
    J Hematol Oncol; 2024 Jan; 17(1):6. PubMed ID: 38297372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acids in cancer.
    Lieu EL; Nguyen T; Rhyne S; Kim J
    Exp Mol Med; 2020 Jan; 52(1):15-30. PubMed ID: 31980738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
    Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
    Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Tumor Microenvironment: Signal Transduction.
    Zhang X; Ma H; Gao Y; Liang Y; Du Y; Hao S; Ni T
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.